Publications by authors named "Luciano Moretti"

Claim this Profile
U
Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial.
Marco Lombardi, Michela Molisana, Eugenio Genovesi, Carlo De Innocentiis, Ugo Limbruno, Luciano Moretti

EuroIntervention· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of temporal correlation in heart rate variability through maximum entropy principle in a minimal pairwise glassy model.
Elena Agliari, Francesco Alemanno, Adriano Barra, Orazio Antonio Barra, Alberto Fachechi, Luciano Moretti

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting cardiac pathologies via machine learning on heart-rate variability time series and related markers.
Elena Agliari, Adriano Barra, Orazio Antonio Barra, Alberto Fachechi, Lorenzo Franceschi Vento, Luciano Moretti

Sci Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrevenTion of contrast-inducEd nephropAThy with urinE alkalinization: the TEATE study design.
Marco Lombardi, Michela Molisana, Eugenio Genovesi, Carlo De Innocentiis, Ugo Limbruno, Luciano Moretti

J Cardiovasc Med (Hagerstown)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial.
Martina Rothenbühler, Marco Valgimigli, Ayodele Odutayo, Enrico Frigoli, Sergio Leonardi, Luciano Moretti

Eur Heart J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registry.
Elisabetta Moscarella, Alfonso Ielasi, Attilio Varricchio, Bernardo Cortese, Bruno Loi, Luciano Moretti

Catheter Cardiovasc Interv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413).
Giuseppe Tarantini, Giulia Masiero, Luca Nai Fovino, Marco Mojoli, Attilio Varricchio, Luciano Moretti

Int J Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient with multiple Swiss cheese aspect coronary lesions: optical coherence tomography to guide coronary angioplasty.
Simona Silenzi, Luca Mariani, Pierfrancesco Grossi, Alessandro Aimi, Luca Di Vito, Luciano Moretti

Future Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry).
Alfonso Ielasi, Bernardo Cortese, Elisabetta Moscarella, Bruno Loi, Giuseppe Tarantini, Luciano Moretti

EuroIntervention· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of 8-mm and open-irrigated gold-tip catheters for typical atrial flutter ablation: Data from a prospective multicenter registry.
Ermenegildo De Ruvo, Antonio Sagone, Giovanni Rovaris, Procolo Marchese, Matteo Santamaria, Luciano Moretti

J Arrhythm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).
Elisabetta Moscarella, Alfonso Ielasi, Attilio Varricchio, Maria Carmen De Angelis, Bruno Loi, Luciano Moretti

Int J Cardiol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
Giuseppe Tarantini, Marco Mojoli, Giulia Masiero, Bernardo Cortese, Bruno Loi, Luciano Moretti

Catheter Cardiovasc Interv· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study.
Iacopo Olivotto, Paolo G Camici, Piera Angelica Merlini, Claudio Rapezzi, Monica Patten, Luciano Moretti

Circ Heart Fail· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with non-ST segment elevation acute coronary syndromes managed without coronary revascularization: A population needing treatment improvement.
Alberto Menozzi, Stefano De Servi, Roberta Rossini, Marco Ferlini, Daniela Lina, Luciano Moretti

Int J Cardiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).
Bernardo Cortese, Alfonso Ielasi, Elisabetta Moscarella, Bruno Loi, Giuseppe Tarantini, Luciano Moretti

Am J Cardiol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Patients with non-ST-elevation acute coronary syndrome managed without coronary revascularization: an undertreated population].
Alberto Menozzi, Leonardo De Luca, Zoran Olivari, Roberta Rossini, Marco Ferlini, Luciano Moretti

G Ital Cardiol (Rome)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.
Simona Silenzi, Pierfrancesco Grossi, Luca Mariani, Chiara Fraccaro, Fabio Vagnarelli, Luciano Moretti

J Interv Cardiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real world single centre experience using the STENTYS self-expanding coronary stent.
Simona Silenzi, Pierfrancesco Grossi, Luca Mariani, Alessandro Aimi, Procolo Marchese, Luciano Moretti

Int J Cardiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study.
Nicole Cristell, Domenico Cianflone, Alessandro Durante, Enrico Ammirati, Diego Vanuzzo, Luciano Moretti

J Am Coll Cardiol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Serge Masson, Roberto Latini, Emanuele Carbonieri, Luciano Moretti, Maria Grazia Rossi

Eur J Heart Fail· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
Serge Masson, Roberto Latini, Valentina Milani, Luciano Moretti, Maria Grazia Rossi

Circ Heart Fail· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
Roberto Marchioli, Giacomo Levantesi, Maria G Silletta, Simona Barlera, Marino Bernardinangeli, Luciano Moretti

Expert Rev Cardiovasc Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Massimo Federico, Monica Bellei, Pauline Brice, Maura Brugiatelli, Arnon Nagler, Luciano Moretti

J Clin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Maurizio Martelli, Filippo Gherlinzoni, Amalia De Renzo, Pier Luigi Zinzani, Antonio De Vivo, Luciano Moretti

J Clin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis